Cargando…
iVAX: An integrated toolkit for the selection and optimization of antigens and the design of epitope-driven vaccines
Computational vaccine design, also known as computational vaccinology, encompasses epitope mapping, antigen selection and immunogen design using computational tools. The iVAX toolkit is an integrated set of tools that has been in development since 1998 by De Groot and Martin. It comprises a suite of...
Autores principales: | , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Taylor & Francis
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4635942/ https://www.ncbi.nlm.nih.gov/pubmed/26155959 http://dx.doi.org/10.1080/21645515.2015.1061159 |
_version_ | 1782399577635160064 |
---|---|
author | Moise, Leonard Gutierrez, Andres Kibria, Farzana Martin, Rebecca Tassone, Ryan Liu, Rui Terry, Frances Martin, Bill De Groot, Anne S |
author_facet | Moise, Leonard Gutierrez, Andres Kibria, Farzana Martin, Rebecca Tassone, Ryan Liu, Rui Terry, Frances Martin, Bill De Groot, Anne S |
author_sort | Moise, Leonard |
collection | PubMed |
description | Computational vaccine design, also known as computational vaccinology, encompasses epitope mapping, antigen selection and immunogen design using computational tools. The iVAX toolkit is an integrated set of tools that has been in development since 1998 by De Groot and Martin. It comprises a suite of immunoinformatics algorithms for triaging candidate antigens, selecting immunogenic and conserved T cell epitopes, eliminating regulatory T cell epitopes, and optimizing antigens for immunogenicity and protection against disease. iVAX has been applied to vaccine development programs for emerging infectious diseases, cancer antigens and biodefense targets. Several iVAX vaccine design projects have had success in pre-clinical studies in animal models and are progressing toward clinical studies. The toolkit now incorporates a range of immunoinformatics tools for infectious disease and cancer immunotherapy vaccine design. This article will provide a guide to the iVAX approach to computational vaccinology. |
format | Online Article Text |
id | pubmed-4635942 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2015 |
publisher | Taylor & Francis |
record_format | MEDLINE/PubMed |
spelling | pubmed-46359422016-02-03 iVAX: An integrated toolkit for the selection and optimization of antigens and the design of epitope-driven vaccines Moise, Leonard Gutierrez, Andres Kibria, Farzana Martin, Rebecca Tassone, Ryan Liu, Rui Terry, Frances Martin, Bill De Groot, Anne S Hum Vaccin Immunother Research Paper Computational vaccine design, also known as computational vaccinology, encompasses epitope mapping, antigen selection and immunogen design using computational tools. The iVAX toolkit is an integrated set of tools that has been in development since 1998 by De Groot and Martin. It comprises a suite of immunoinformatics algorithms for triaging candidate antigens, selecting immunogenic and conserved T cell epitopes, eliminating regulatory T cell epitopes, and optimizing antigens for immunogenicity and protection against disease. iVAX has been applied to vaccine development programs for emerging infectious diseases, cancer antigens and biodefense targets. Several iVAX vaccine design projects have had success in pre-clinical studies in animal models and are progressing toward clinical studies. The toolkit now incorporates a range of immunoinformatics tools for infectious disease and cancer immunotherapy vaccine design. This article will provide a guide to the iVAX approach to computational vaccinology. Taylor & Francis 2015-07-09 /pmc/articles/PMC4635942/ /pubmed/26155959 http://dx.doi.org/10.1080/21645515.2015.1061159 Text en © 2015 The Author(s). Published with license by Taylor & Francis Group, LLC http://creativecommons.org/licenses/by-nc/3.0/ This is an Open Access article distributed under the terms of the Creative Commons Attribution-Non-Commercial License http://creativecommons.org/licenses/by-nc/3.0/, which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited. The moral rights of the named author(s) have been asserted. |
spellingShingle | Research Paper Moise, Leonard Gutierrez, Andres Kibria, Farzana Martin, Rebecca Tassone, Ryan Liu, Rui Terry, Frances Martin, Bill De Groot, Anne S iVAX: An integrated toolkit for the selection and optimization of antigens and the design of epitope-driven vaccines |
title | iVAX: An integrated toolkit for the selection and optimization of antigens and the design of epitope-driven vaccines |
title_full | iVAX: An integrated toolkit for the selection and optimization of antigens and the design of epitope-driven vaccines |
title_fullStr | iVAX: An integrated toolkit for the selection and optimization of antigens and the design of epitope-driven vaccines |
title_full_unstemmed | iVAX: An integrated toolkit for the selection and optimization of antigens and the design of epitope-driven vaccines |
title_short | iVAX: An integrated toolkit for the selection and optimization of antigens and the design of epitope-driven vaccines |
title_sort | ivax: an integrated toolkit for the selection and optimization of antigens and the design of epitope-driven vaccines |
topic | Research Paper |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4635942/ https://www.ncbi.nlm.nih.gov/pubmed/26155959 http://dx.doi.org/10.1080/21645515.2015.1061159 |
work_keys_str_mv | AT moiseleonard ivaxanintegratedtoolkitfortheselectionandoptimizationofantigensandthedesignofepitopedrivenvaccines AT gutierrezandres ivaxanintegratedtoolkitfortheselectionandoptimizationofantigensandthedesignofepitopedrivenvaccines AT kibriafarzana ivaxanintegratedtoolkitfortheselectionandoptimizationofantigensandthedesignofepitopedrivenvaccines AT martinrebecca ivaxanintegratedtoolkitfortheselectionandoptimizationofantigensandthedesignofepitopedrivenvaccines AT tassoneryan ivaxanintegratedtoolkitfortheselectionandoptimizationofantigensandthedesignofepitopedrivenvaccines AT liurui ivaxanintegratedtoolkitfortheselectionandoptimizationofantigensandthedesignofepitopedrivenvaccines AT terryfrances ivaxanintegratedtoolkitfortheselectionandoptimizationofantigensandthedesignofepitopedrivenvaccines AT martinbill ivaxanintegratedtoolkitfortheselectionandoptimizationofantigensandthedesignofepitopedrivenvaccines AT degrootannes ivaxanintegratedtoolkitfortheselectionandoptimizationofantigensandthedesignofepitopedrivenvaccines |